Impaired microvascular properties in uncomplicated type 1 diabetes identified by Doppler ultrasound of the ocular circulation

Abstract

Objective: Quantification of Doppler flow velocity waveforms has been shown to predict adverse cardiovascular outcomes and identify altered downstream haemodynamics and vascular damage in a number of organ beds. We employed novel techniques to quantify Doppler flow velocity waveforms from the retro bulbar circulation.

Methods and results: In total, 39 patients with uncomplicated Type 1 diabetes mellitus, and no other significant cardiovascular risk factors were compared with 30 control subjects. Flow velocity waveforms were captured from the ophthalmic artery (OA), central retinal artery (CRA) and the common carotid artery. The flow velocity profiles were analysed in the time domain to calculate the resistive index (RI), and time-frequency domain using novel discrete wavelet transform methods for comparison. Analysis of flow waveforms from the OA and CRA identified specific frequency band differences between groups, occurring independently of potential haemodynamic or metabolic confounding influences. No changes were identified in the calculated RI from any arterial site.

Conclusion: Novel analysis of the arterial flow velocity waveforms recorded from the retro bulbar circulation identified quantifiable differences in Doppler flow velocity waveform morphology in patients with diabetes prior to the development of overt retinopathy. The technique may be useful as an additional marker of cardiovascular risk.

Keywords

Endothelium microcirculation ocular ultrasound type 1 diabetes

References

Feskens EJ and Kromhout D. Glucose tolerance and the risk of cardiovascular disease: the Zutphen Study . J Clin Epidemiol 1992; 45: 1327-1334.

Soedamah-Muthu SS , Fuller JH , Mulnier HE , Raleigh VS , Lawrenson RA and Colhoun HM High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. Diabetes Care 2006; 29: 798-804.

Soedamah-Muthu SS , Fuller JH , Mulnier HE , Raleigh VS , Lawrenson RA and Colhoun HM All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999. Diabetologia 2006; 49: 660-666.

Touyz RM Vascular remodeling, retinal arteries, and hypertension. Hypertension 2007; 50: 603-604.

Liew G. , Wang JJ , Mitchell P. and Wong TY Retinal vascular imaging: a new tool in microvascular disease research. Circ Cardiovasc Imaging 2008; 1: 156-161.

Ikram MK , Witteman JC , Vingerling JR , Breteler MM , Hofman A. and de Jong PT Retinal vessel diameters and risk of hypertension: the Rotterdam study. Hypertension 2006; 47: 189-194.

Ikram MK , Janssen JA , Roos AM , Rietveld I. , Witteman JC , Breteler MM , et al. Retinal vessel diameters and risk of impaired fasting glucose or diabetes: the Rotterdam study. Diabetes 2006; 55: 506-510.

O’Rourke MF and Safar ME Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005; 46: 200-204.

Cheung N. , Wang JJ , Klein R. , Couper DJ , Sharrett AR and Wong TY Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Diabetes Care 2007 ; 30: 1742-1746.

10.

Cooper LS , Wong TY , Klein R. , Sharrett AR , Bryan RN , Hubbard LD , et al. Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study. Stroke 2006; 37: 82-86.

11.

Wong TY , Klein R. , Sharrett AR , Duncan BB , Couper DJ , Tielsch JM , et al. Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study. JAMA 2002; 287: 1153-1159.

12.

Stitt A. , Gardiner TA , Alderson NL , Canning P. , Frizzell N. , Duffy N. , et al. The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 2002; 51: 2826-2832.

13.

Stitt AW , Anderson HR , Gardiner TA and Archer DB Diabetic retinopathy: quantitative variation in capillary basement membrane thickening in arterial or venous environments. Br J Ophthalmol 1994; 78: 133-137.

14.

Ljubimov AV , Burgeson RE , Butkowski RJ , Couchman JR , Zardi L. , Ninomiya Y. , et al. Basement membrane abnormalities in human eyes with diabetic retinopathy. J Histochem Cytochem 1996; 44: 1469-1479.

15.

Wong PY Retinal and cardiovascular diseases: "Common soil theory". Ann Ann Acad Med Singapore 2007; 36: 4-8.

16.

Bude RO and Rubin JM Effect of downstream cross-sectional area of an arterial bed on the resistive index and the early systolic acceleration. Radiology 1999; 212: 732-738.

17.

Bude RO and Rubin JM Relationship between the resistive index and vascular compliance and resistance . Radiology 1999; 211: 411-417.

18.

Wright SA , O’Prey FM , Rea DJ , Plumb RD , Gamble AJ , Leahey WJ , et al. Microcirculatory hemodynamics and endothelial dysfunction in systemic lupus erythematosus. Arterioscler Thromb Vasc Biol 2006; 26: 2281-2287.

19.

Lockhart CJ , Gamble AJ , Rea D. , Hughes S. , McGivern RC , Wolsley C. , et al. Nitric oxide modulation of ophthalmic artery blood flow velocity waveform morphology in healthy volunteers. Clin Sci (Lond) 2006; 111: 47-52.

20.

Bracic M. and Stefanovska A. Wavelet-based analysis of human blood-flow dynamics. Bull Math Biol 1998; 60: 919-935.

21.

Addison PS The Illustrated Wavelet Transform Handbook. Bristol: Institute of Physics Publishing, 2002.

22.

Ubeyli ED Detection of arterial disorders by spectral analysis techniques. Biomed Mater Eng 2007; 17: 183-189.

23.

Guo Z. , Durand LG and Lee HC Comparison of time-frequency distribution techniques for analysis of simulated Doppler ultrasound signals of the femoral artery. IEEE Trans Biomed Eng 1994; 41: 332-342.

24.

Cardoso JC , Ruano MG and Fish PJ Nonstationarity broadening reduction in pulsed Doppler spectrum measurements using time-frequency estimators. IEEE Trans Biomed Eng 1996; 43: 1176-1186.

25.

Cohn JN Arterial stiffness, vascular disease, and risk of cardiovascular events. Circulation 2006; 113: 601-603.

26.

Serne EH , de Jongh RT , Eringa EC , IJzerman RG and Stehouwer CD Microvascular dysfunction: a potential pathophysiological role in the metabolic syndrome. Hypertension 2007; 50: 204-211.

27.

Levy BI , Ambrosio G. , Pries AR and Struijker-Boudier HA

Microcirculation in hypertension: a new target for treatment?

Circulation 2001; 104: 735-740.

28.

Cheung N. , Wang JJ , Rogers SL , Brancati F. , Klein R. , Sharrett AR and Wong TY Diabetic retinopathy and risk of heart failure. J Am Coll Cardiol 2008; 51: 1573-1578.

29.

Lockhart CJ , Hamilton PK , Quinn CE and McVeigh GE End-organ dysfunction and cardiovascular outcomes: the role of the microcirculation . Clin Sci (Lond) 2009 ; 116: 175-190.

30.

Ozkiris A. , Erkilic K. , Koc A. and Mistik S. Effect of atorvastatin on ocular blood flow velocities in patients with diabetic retinopathy. Br J Ophthalmol 2007; 91: 69-73.

31.

Lachin JM , Genuth S. , Nathan DM , Zinman B. and Rutledge BN Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial - revisited. Diabetes 2008; 57: 995-1001.

32.

Radermacher J. , Ellis S. and Haller H. Renal resistance index and progression of renal disease. Hypertension 2002; 39: 699-703.

33.

Hausberg M. , Lang D. , Barenbrock M. and Kosch M.

What do Doppler indices of renal perfusion tell us for the evaluation of renal disease?

J Hypertens 2005; 23: 1795-1797.

34.

Heine GH , Reichart B. , Ulrich C. , Kohler H. and Girndt M.

Do ultrasound renal resistance indices reflect systemic rather than renal vascular damage in chronic kidney disease?

Nephrol Dial Transplant 2007; 22: 163-170.

35.

Polska E. , Kircher K. , Ehrlich P. , Vecsei PV and Schmetterer L. RI in central retinal artery as assessed by CDI does not correspond to retinal vascular resistance. Am J Physiol Heart Circ Physiol 2001; 280: H1442-H1447.

36.

Saunders HM , Burns PN , Needleman L. , Liu JB , Boston R. , Wortman JA , et al. Hemodynamic factors affecting uterine artery Doppler waveform pulsatility in sheep. J Ultrasound Med 1998; 17: 357-368.

37.

Merimee TJ Diabetic retinopathy. A synthesis of perspectives. N Engl J Med 1990; 322: 978-983.

38.

Quick CM , Berger DS and Noordergraaf A. Constructive and destructive addition of forward and reflected arterial pulse waves. Am J Physiol Heart Circ Physiol 2001 ; 280: H1519-H1527.

39.

Berger DS , Li JK and Noordergraaf A. Arterial wave propagation phenomena, ventricular work, and power dissipation . Ann Biomed Eng 1995; 23: 804-811.

40.

Lacy PS , O’Brien DG , Stanley AG , Dewar MM , Swales PP and Williams B. Increased pulse wave velocity is not associated with elevated augmentation index in patients with diabetes. J Hypertens 2004; 22: 1937-1944.

41.

Michelson G. , Harazny J. , Schmieder RE , Berendes R. , Fiermann T. and Warntges S. Fourier analysis of the envelope of the ophthalmic artery blood flow velocity: age- and blood pressure related impact. Hypertension 2007; 50: 964-969.